Necrobiotic xanthogranuloma

International Journal of Dermatology

Volumn 48, Issue 1, 2009, Pages 1-10

  Spicknall, Kerith E ^a,b   Mehregan, David A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pinkus Dermatopathology Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA2B INTERFERON; AZATHIOPRINE; CHLORAMBUCIL; CHOLESTEROL; CLOFAZIMINE; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; ETRETINATE; GLUCOSE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN KAPPA CHAIN; MELPHALAN; METHOTREXATE; PSORALEN; STEROID; THALIDOMIDE; TRIACYLGLYCEROL;

BONE MARROW BIOPSY; CARBON DIOXIDE LASER; COMBINATION CHEMOTHERAPY; ERYTHROCYTE SEDIMENTATION RATE; EXCISION; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOPENIA; MONOCLONAL IMMUNOGLOBULINEMIA; MONOTHERAPY; MULTIPLE MYELOMA; NECROBIOTIC XANTHOGRANULOMA; NEODYMIUM LASER; NEUTROPENIA; OPHTHALMOLOGY; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMAPHERESIS; PROTEIN ELECTROPHORESIS; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; XANTHOGRANULOMA;

BIOPSY, NEEDLE; BONE MARROW CELLS; DRUG THERAPY, COMBINATION; FEMALE; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NECROBIOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; XANTHOMATOSIS;

EID: 58149299512     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03912.x     Document Type: Review

References (66)

1. Elder DE. Lever's Histopathology of the Skin, 9th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2005: 697-698.
2. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1980; 3: 257-270.
3. Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch Dermatol 1992; 128: 94-100.
4. Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: Long-term outcome of ocular and systemic involvement. Am J Ophthalmol 2000; 129: 651-657.
5. Winkelmann RK, Dahl PR, Perniciaro C. Asteroid bodies and other cytoplasmic inclusions in necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1998; 38: 967-970.
6. Flann S, Wain EM, Halpern S, et al. Necrobiotic xanthogranuloma with paraproteinaemia. Clin Exp Dermatol 2006; 31: 248-251.
7. Sabet LM, Wexler D, Salama S, et al. An unusual cause of refractive chronic bilateral leg ulceration. J Cutan Med Surg 2004; 8: 432-437.
8. Chang SE, Lee WS, Lee MW, et al. A case of necrobiotic xanthogranuloma without paraproteinemia presenting as a solitary tumor on the thigh. Int J Dermatol 2003; 42: 470-472.
9. Criado PR, Vasconcellos C, Pegas JR, et al. Necrobiotic xanthogranuloma with lambda paraproteinemia: Case report of successful treatment with melphalan and prednisone. J Dermatol Treat 2002; 13: 87-89.
10. Betts CM, Pasquinelli G, Costa AM, et al. Necrobiotic xanthogranuloma without periorbital involvement: An ultrastructural investigation. Ultrastruct Pathol 2001; 25: 437-444.
11. Chave TA, Hutchinson PE. Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation. Clin Exp Dermatol 2001; 26: 493-496.
12. Chave TA, Chowdhury MM, Holt PJ. Recalcitrant necrobiotic xanthogranuloma responding to pulsed high-dose oral dexamethasone plus maintenance therapy with oral prednisolone. Br J Dermatol 2001; 144: 158-161.
13. Kossard S, Chow E, Wilkinson B, et al. Lipid and giant cell poor necrobiotic xanthogranuloma. J Cutan Pathol 2000; 27: 374-378.
14. Nestle FO, Hofbauer G, Burg G. Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. Dermatology 1999; 198: 434-435.
15. McGregor JM, Miller J, Smith NP, et al. Necrobiotic xanthogranuloma without periorbital lesions. J Am Acad Dermatol 1993; 29: 466-469.
16. Cornblath WT, Dotan SA, Trobe JD, et al. Varied clinical spectrum of necrobiotic xanthogranuloma. Ophthalmology 1992; 99: 103-107.
17. Hauser C, Schifferli J, Saurat JH. Complement consumption in a patient with necrobiotic xanthogranuloma and paraproteinemia. J Am Acad Dermatol 1991; 24: 908-911.
18. Oumeish OY, Oumeish I, Tarawneh M, et al. Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's lymphoma developing into chronic lymphocytic leukemia: The first case reported in the literature and review of the literature. Int J Dermatol 2006; 45: 306-310.
19. Smith HG, Sargent LA, Lundgrin DB. Necrobiotic xanthogranuloma of the chest wall. Dermatol Online J 2006; 12: 12.
20. Gun D, Demircay Z, Demirkesen C. Necrobiotic xanthogranuloma in a burn scar. Int J Dermatol 2004; 43: 293-295.
21. Burdick AE, Sanchez J, Elgart GW. Necrobiotic xanthogranuloma associated with a benign monoclonal gammopathy. Cutis 2003; 72: 47-50.
22. Chandra S, Finklestein E, Gill D. Necrobiotic xanthogranuloma occurring within linear morphoea. Australas J Dermatol 2002; 43: 52-54.
23. Machado S, Alves R, Lima M, et al. Cutaneous necrobiotic xanthogranuloma (NXG) - successfully treated with low dose chlorambucil. Eur J Dermatol 2001; 11: 458-462.
24. Georgiou S, Monastirli A, Kapranos N, et al. Interferon alpha-2a monotherapy for necrobiotic xanthogranuloma. Acta Derm Venereol 1999; 79: 484-485.
25. Johnston KA, Grimwood RE, Meffert JJ, et al. Necrobiotic xanthogranuloma with paraproteinemia: An evolving presentation. Cutis 1997; 59: 333-336.
26. Lebey PB, Determer I, Bazex J, et al. Periorbital papules and nodules: necrobiotic xanthogranuloma. Arch Dermatol 1997; 133: 102.
27. Reeder CB, Connolly SM, Winkelmann RK. The evolution of Hodgkin's disease and necrobiotic xanthogranuloma syndrome. Mayo Clin Proc 1991; 66: 1222-1224.
28. Ziemer M, Wedding U, Sander CS, et al. Necrobiotic xanthogranuloma - rapid progression under treatment with melphalan. Eur J Dermatol 2005; 15: 363-365.
29. Vieira V, Del Pozo J, Martinez W, et al. Necrobiotic xanthogranuloma associated with lymphoplasmacytic lymphoma. Palliative treatment with carbon dioxide laser. Eur J Dermatol 2005; 15: 182-185.
30. Nishimura M, Takano-Nishimura Y, Yano I, et al. Necrobiotic xanthogranuloma in a human T-lymphotropic virus type 1 carrier. J Am Acad Dermatol 1992; 27: 886-889.
31. Bara C, Barbarot S, Hamidou M, et al. [Systemic necrobiotic xanthogranuloma with initial pericardial and pulmonary involvement]. Ann Dermatol Venereol 2003; 130: 341-344.
32. Yasukawa K, Kato N, Hamasaka A, et al. Necrobiotic xanthogranuloma: isolated skeletal muscle involvement and unusual changes. J Am Acad Dermatol 2005; 52: 729-731.
33. Barzilai A, Trau H, Shpiro D, et al. Necrobiotic xanthogranuloma with paraproteinemia. Cutis 1996; 57: 320-322.
34. Ferrara G, Palombi N, Lipizzi A, et al. Nonnecrobiotic necrobiotic xanthogranuloma. Am J Dermatopathol 2007; 29: 306-308.
35. Muscardin LM, Mastroianni A, Chistolini A, et al. Necrobiotic xanthogranuloma without periorbital lesions and without paraproteinaemia. J Eur Acad Dermatol Venereol 2003; 17: 233-235.
36. Russo GG. Necrobiotic xanthogranuloma with scleroderma. Cutis 2002; 70: 311-316.
37. Stork J, Kodetova D, Vosmik F, et al. Necrobiotic xanthogranuloma presenting as a solitary tumor. Am J Dermatopathol 2000; 22: 453-456.
38. Winkelmann RK, Litzow MR, Umbert IJ, et al. Giant cell granulomatous pulmonary and myocardial lesions in necrobiotic xanthogranuloma with paraproteinemia. Mayo Clin Proc 1997; 72: 1028-1033.
39. Fortson JS, Schroeter AL. Necrobiotic xanthogranuloma with IgA paraproteinemia and extracutaneous involvement. Am J Dermatopathol 1990; 12: 579-584.
40. Venencie PY, Le Bras P, Toan ND, et al. Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1995; 32: 666-667.
41. Scupham RK, Fretzin DF. Necrobiotic xanthogranuloma with paraproteinemia. Arch Pathol Lab Med 1989; 113: 1389-1391.
42. Wells J, Gillespie R, Zardawi I. Case of recalcitrant necrobiotic xanthogranuloma. Australas J Dermatol 2004; 45: 213-215.
43. Shah KC, Poonnoose SI, George R, et al. Necrobiotic xanthogranuloma with cutaneous and cerebral manifestations. Case report and review of the literature. J Neurosurg 2004; 100: 1111-1114.
44. Plotnick H, Taniguchi Y, Hashimoto K, et al. Periorbital necrobiotic xanthogranuloma and stage I multiple myeloma. Ultrastructure and response to pulsed dexamethasone documented by magnetic resonance imaging. J Am Acad Dermatol 1991; 25: 373-377.
45. Kunikata N, Kikuchi K, Hashimoto A, et al. Necrobiotic xanthogranuloma of the nose without paraproteinemia. J Dermatol 2006; 33: 809-812.
46. Wee SA, Shupack JL. Necrobiotic xanthogranuloma. Dermatol Online J 2005; 11: 24.
47. Zelger B, Eisendle K, Mensing C, et al. Detection of spirochetal micro-organisms by focus-floating microscopy in necrobiotic xanthogranuloma. J Am Acad Dermatol 2007; 57: 1026-1030.
48. Torabian SZ, Fazel N, Knuttle R. Necrobiotic xanthogranuloma treated with chlorambucil. Dermatol Online J 2006; 12: 11.
49. Martinez Fernandez M, Rodriguez Prieto MA, Ruiz Gonzalez I, et al. Necrobiotic xanthogranuloma associated with myeloma. J Eur Acad Dermatol Venereol 2004; 18: 328-331.
50. Valentine EA, Friedman HD, Zamkoff KW, et al. Necrobiotic xanthogranuloma with IgA multiple myeloma: A case report and literature review. Am J Hematol 1990; 35: 283-285.
51. Matsuura F, Yamashita S, Hirano K, et al. Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia - a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis 1999; 142: 355-365.
52. Elner VM, Mintz R, Demirci H, et al. Local corticosteroid treatment of eyelid and orbital xanthogranuloma. Ophthal Plast Reconstr Surg 2006; 22: 36-40.
53. Langlois S, Brochot P, Reguiai Z, et al. Necrobiotic xanthogranuloma with multiple myeloma Case report and pathogenic hypotheses. Joint Bone Spine 2006; 73: 120-122.
54. Finan MC, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia: A review of 22 cases. Medicine (Baltimore) 1986; 65: 376-388.
55. Hunter L, Burry AF. Necrobiotic xanthogranuloma: A systemic disease with paraproteinemia. Pathology 1985; 17: 533-536.
56. Frank SB, Weidman AI. Xanthoma disseminatum: An unusual form with extension of xanthomatous changes into muscle. Arch Dermatol Syphilol 1952; 64: 88-94.
57. Novak PM, Robbins TO, Winkelmann RK. Necrobiotic xanthogranuloma with myocardial lesions and nodular transformation of the liver. Hum Pathol 1992; 23: 195-196.
58. Umbert I, Winkelmann RK. Necrobiotic xanthogranuloma with cardiac involvement. Br J Dermatol 1995; 133: 438-443.
59. Tucker NA, Discepola MJ, Blanco G, et al. Necrobiotic xanthogranuloma without dermatologic involvement. Can J Ophthalmol 1997; 32: 396-399.
60. Luck J, Layton A, Noble BA. Necrobiotic xanthogranuloma with orbital involvement. J R Soc Med 1992; 85: 357-358.
61. Wilhelmus KR, Yen MT, Rice L, et al. Necrobiotic xanthogranuloma with posterior scleritis. Arch Ophthalmol 2006; 124: 748.
62. Amer R, Pe'er J, Pappo O, et al. Necrobiotic xanthogranuloma associated with choroidal infiltration and syncytial giant cell hepatitis. J Neuroophthalmol 2005; 25: 189-192.
63. Schaudig U, Al-Samir K. Upper and lower eyelid reconstruction for severe disfiguring necrobiotic xanthogranuloma. Orbit 2004; 23: 65-76.
64. Meyer S, Szeimies RM, Landthaler M, et al. Cyclophosphamide-dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement. Br J Dermatol 2005; 153: 443-445.
65. Bullock JD, Bartley GB, Campbell RJ, et al. Necrobiotic xanthogranuloma with paraproteinemia. Case report and a pathogenetic theory. Ophthalmology 1986; 93: 1233-1236.
66. Brigden ML. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance? Postgrad Med 1999; 106: 135-142.